News
-
-
COMMUNIQUÉ DE PRESSE
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques -
-
-
COMMUNIQUÉ DE PRESSE
High level of approval at the Annual General Meeting - vote of confidence in the Netfonds AG's strategy
Netfonds AG's Annual General Meeting sees high level of approval, demonstrating shareholders' confidence in company's strategy. Approval rate of 99.99% for balance sheet profit appropriation -
-
-
COMMUNIQUÉ DE PRESSE
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
Bausch Health appoints Michael Goettler and Sandra Leung to its Board of Directors, expanding the Board to twelve members. The new appointments bring extensive pharmaceutical industry expertise and leadership experience -
COMMUNIQUÉ DE PRESSE
Trump Lit the Match, SMX Is the Accelerant In The Newly Legitimized Digital Market
President Donald Trump signed the GENIUS Act into law, marking a systemic shift in the U.S. financial system and legitimizing digital assets. SMX introduces Plastic Cycle Token for sustainable manufacturing -
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathways in A
Telomir Pharmaceuticals announces promising preclinical results showing the compound Telomir-1 restores mitochondrial function without triggering oxidative stress or cell proliferation in Progeria human cells
